Spinal injury drug may tackle Alzheimer's DNA damage and inflammation
In short
- The drug was originally developed for spinal cord injuries.
- Researchers found it can address DNA damage and brain inflammation linked to Alzheimer's.
- The experimental treatment has been tested for initial safety in humans.
Why it's good news
The study points to DNA damage and inflammation as features the drug may target. The treatment is still experimental, and the source reports only initial safety testing in humans. Its value depends on whether later studies show it helps people with the disease.
Advertisement
From ScienceDaily
Scientists have discovered that a drug originally developed for spinal cord injuries can tackle several key features of Alzheimerβs disease, including DNA damage and inflammation. Already tested for initial safety in humans, the experimental treatment could offer a faster path toward therapies that target the disease at its roots.
Ask this story
More like this
Advertisement